National Alliance of Sickle Cell Centers Consensus Recommendations on Sickle Cell Disease Health Maintenance: A
Seethal A Jacob1,2, Melissa Frei-Jones3, Sana Saif-Ur-Rehman4
1Division of Pediatric Hematology Oncology Stem Cell Transplant, Department of Pediatrics, Riley Hospital for Children, Indianapolis, Indiana.
Importance:
The most common inherited blood disorder in the world, sickle cell disease (SCD) is a known global health concern. While survival of children into adulthood has improved significantly over the last few decades in high-resource countries, substantial gaps in care standards and limited practice harmonization persist.
Objective:
To provide up-to-date recommendations for preventive care and treatment of all people living with SCD and its related comorbidities.
Evidence Review:
As part of the National Alliance of Sickle Cell Centers (NASCC), 41 pediatric and adult sickle cell disease experts developed consensus standards and recommendations based on available evidence and expert consensus garnered during an in-depth review of the literature. For these recommendations, there were 3 separate consensus panels (0-2 years, 2-18 years, and >18 years]) held in 2022. The initial expert panels included representation from 41 NASCC-recognized SCD centers (during the first 2 votes) and the third and final vote in 2023 included representatives from 81 NASCC-recognized centers. The primary focus was on: (1) preventative care including screening recommendations, (2) management of acute complications, and (3) treatment options.
Findings:
In this modified Delphi consensus statement, the experts developed consensus standards and recommendations for the clinical care of people living with SCD throughout the lifespan, as well as identified gaps in current evidence that need additional research. Standards and recommendations included routine screening and education, management of acute complications, as well as disease-modifying treatments such as hydroxyurea.
Conclusions And Relevance:
People with SCD require coordinated and consistent care starting soon after birth in an SCD center and throughout their lives; SCD is a chronic condition with a highly heterogenous phenotype necessitating lifelong care through an SCD center in collaboration with clinicians in multiple areas of medicine including primary care. Future work should prioritize the management of timing of initiation and precision use of disease-modifying therapies, infection management and prevention, and discussion on transformative therapies.
Related Concept Videos
01:30National Nursing Organizations II
The AACN emphasizes a healthy work environment through six standards to achieve an optimal patient outcome. The standards are appropriate staffing, meaningful recognition, collaboration, authentic leadership, effective communication, and decision-making. In addition, AACN provides certification programs, webinars, journals, and...
01:23International Nursing Organizations I
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...
01:26Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
01:22Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...
01:29Documentation in Long-Term and Home Healthcare Setting
Long-Term Care Facilities
01:27Nursing Clinical Information System
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include: